✦ LIBER ✦
95 Peginterferon alfa-2A (40KD) (PEGASYS®) monotherapy is more effective than lamivudine monotherapy in the treatment of HBEAG-negative chronic hepatitis B: 72-week results from a phase III, partially double-blind study of PEGASYS® alone vs PEGASYS® plus lamivudine vs lamivudine
✍ Scribed by P. Marcellin; G.K.K. Lau; F. Bonino; P. Farci; S. Hadziyannis; R. Jin; Z.-M. Lu; T. Piratvisuth; G. Germanidis; N. Pluck
- Book ID
- 117372925
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 64 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.